SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007960
Filing Date
2022-05-10
Accepted
2022-05-10 07:00:43
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220331x10q.htm   iXBRL 10-Q 1587031
2 EX-31.1 tmb-20220331xex31d1.htm EX-31.1 7124
3 EX-31.2 tmb-20220331xex31d2.htm EX-31.2 7114
4 EX-32.1 tmb-20220331xex32d1.htm EX-32.1 9200
5 GRAPHIC tmb-20220331x10q001.jpg GRAPHIC 17235
  Complete submission text file 0001558370-22-007960.txt   5811962

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20220331.xsd EX-101.SCH 43703
7 EX-101.CAL tmb-20220331_cal.xml EX-101.CAL 35641
8 EX-101.DEF tmb-20220331_def.xml EX-101.DEF 115279
9 EX-101.LAB tmb-20220331_lab.xml EX-101.LAB 356605
10 EX-101.PRE tmb-20220331_pre.xml EX-101.PRE 257703
56 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220331x10q_htm.xml XML 1029310
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37410 | Film No.: 22907287
SIC: 2834 Pharmaceutical Preparations